US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older - Reuters
PorAinvest
sábado, 31 de mayo de 2025, 12:50 am ET1 min de lectura
MRNA--
The vaccine, which uses mRNA technology, has also been approved for individuals aged 12 to 64 with at least one or more underlying risk factors, such as diabetes, heart disease, or cancer. This expanded approval aims to protect vulnerable populations who are at higher risk of severe COVID-19 complications [1].
The approval follows a period of intense scrutiny and debate over the necessity and effectiveness of COVID-19 vaccines for various age groups and risk profiles. The Centers for Disease Control and Prevention (CDC) has recently removed COVID-19 vaccinations from the list of recommended vaccines for healthy children and pregnant women, citing insufficient evidence that healthy individuals under 65 would benefit from additional shots [2].
The CDC's new recommendations align with the World Health Organization's (WHO) guidelines, which do not recommend annual shots for healthy individuals under age 50, unless they have not been previously vaccinated against COVID-19. However, the WHO does recommend that pregnant women receive an updated COVID-19 vaccine during each pregnancy [2].
This development is part of a broader trend in public health policy, reflecting a shift towards more targeted and evidence-based approaches to vaccine recommendations. As the pandemic continues to evolve, these decisions will play a crucial role in shaping the future of COVID-19 vaccination strategies.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L2N3S300Z:0-us-fda-approves-moderna-s-next-gen-covid-vaccine-for-adults-65-or-older/
[2] https://www.krtv.com/health/cdc-to-eliminate-covid-19-vaccine-recommendations-for-children-pregnant-women
US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older - Reuters
The U.S. Food and Drug Administration (FDA) has approved Moderna's next-generation COVID-19 vaccine for all individuals aged 65 and older, marking a significant step in the ongoing battle against the pandemic. This approval comes after the FDA tightened its regulatory requirements, indicating a more stringent review process for new vaccines [1].The vaccine, which uses mRNA technology, has also been approved for individuals aged 12 to 64 with at least one or more underlying risk factors, such as diabetes, heart disease, or cancer. This expanded approval aims to protect vulnerable populations who are at higher risk of severe COVID-19 complications [1].
The approval follows a period of intense scrutiny and debate over the necessity and effectiveness of COVID-19 vaccines for various age groups and risk profiles. The Centers for Disease Control and Prevention (CDC) has recently removed COVID-19 vaccinations from the list of recommended vaccines for healthy children and pregnant women, citing insufficient evidence that healthy individuals under 65 would benefit from additional shots [2].
The CDC's new recommendations align with the World Health Organization's (WHO) guidelines, which do not recommend annual shots for healthy individuals under age 50, unless they have not been previously vaccinated against COVID-19. However, the WHO does recommend that pregnant women receive an updated COVID-19 vaccine during each pregnancy [2].
This development is part of a broader trend in public health policy, reflecting a shift towards more targeted and evidence-based approaches to vaccine recommendations. As the pandemic continues to evolve, these decisions will play a crucial role in shaping the future of COVID-19 vaccination strategies.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L2N3S300Z:0-us-fda-approves-moderna-s-next-gen-covid-vaccine-for-adults-65-or-older/
[2] https://www.krtv.com/health/cdc-to-eliminate-covid-19-vaccine-recommendations-for-children-pregnant-women

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios